Related references
Note: Only part of the references are listed.Does Gender Influence Outcome in Schizophrenia?
Mary V. Seeman
PSYCHIATRIC QUARTERLY (2019)
N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis
Philippe Conus et al.
SCHIZOPHRENIA BULLETIN (2018)
Translational Significance of Selective Estrogen Receptor Modulators in Psychiatric Disorders
Mohammad M. Khan
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2018)
N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: a double-blind randomized placebo-controlled trial
Paul Klauser et al.
TRANSLATIONAL PSYCHIATRY (2018)
N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects
Alessandro Minarini et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry
L. G. Nucifora et al.
TRANSLATIONAL PSYCHIATRY (2017)
Two-hit model of schizophrenia induced by neonatal immune activation and peripubertal stress in rats: Study of sex differences and brain oxidative alterations
Aline Santos Monte et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Antioxidant Treatment with N-acetyl Cysteine Prevents the Development of Cognitive and Social Behavioral Deficits that Result from Perinatal Ketamine Treatment
Aarron Phensy et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2017)
Higher Striatal Iron Concentration is Linked to Frontostriatal Underactivation and Poorer Memory in Normal Aging
Gregoria Kalpouzos et al.
CEREBRAL CORTEX (2017)
Gender and estrous cycle influences on behavioral and neurochemical alterations in adult rats neonatally administered ketamine
Vladia Celia Moreira Borella et al.
DEVELOPMENTAL NEUROBIOLOGY (2016)
Activation of G protein-coupled estrogen receptor 1 (GPER-1) ameliorates blood-brain barrier permeability after global cerebral ischemia in ovariectomized rats
Dan Lu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
17β-ESTRADIOL/N-ACETYLCYSTEINE INTERACTION ENHANCES THE NEUROPROTECTIVE EFFECT ON DOPAMINERGIC NEURONS IN THE WEAVER MODEL OF DOPAMINE DEFICIENCY
K. Botsakis et al.
NEUROSCIENCE (2016)
Behaviour and prefrontal protein differences in C57BL/6N and 129 X1/SvJ mice
Xiaofan Zhang et al.
BRAIN RESEARCH BULLETIN (2015)
Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia
Kim Q. Do et al.
SCHIZOPHRENIA BULLETIN (2015)
Targeting Glia with N-Acetylcysteine Modulates Brain Glutamate and Behaviors Relevant to Neurodevelopmental Disorders in C57BL/6J Mice
Alice M. S. Durieux et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2015)
Single and combined effects of prenatal immune activation and peripubertal stress on parvalbumin and reelin expression in the hippocampal formation
Sandra Giovanoli et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Methamphetamine Enhances the Development of Schizophrenia in First-Degree Relatives of Patients With Schizophrenia
Huabing Li et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2014)
Prenatal Exposure to the Viral Mimetic Poly I:C Alters Fetal Brain Cytokine Expression and Postnatal Behaviour
Udani Ratnayake et al.
DEVELOPMENTAL NEUROSCIENCE (2014)
The role of the hippocampus in flexible cognition and social behavior
Rachael D. Rubin et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2014)
Different susceptibility of prefrontal cortex and hippocampus to oxidative stress following chronic social isolation stress
Jelena Zlatkovic et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia
Hong Lin et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2014)
Juvenile Antioxidant Treatment Prevents Adult Deficits in a Developmental Model of Schizophrenia
Jan-Harry Cabungcal et al.
NEURON (2014)
Estrogen Receptors, the Hippocampus, and Memory
Linda A. Bean et al.
NEUROSCIENTIST (2014)
Sex differences in the adolescent developmental trajectory of parvalbumin interneurons in the hippocampus: A role for estradiol
YeeWen Candace Wu et al.
PSYCHONEUROENDOCRINOLOGY (2014)
N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities
Reza Bavarsad Shahripour et al.
BRAIN AND BEHAVIOR (2014)
Early-Life Insults Impair Parvalbumin Interneurons via Oxidative Stress: Reversal by N-Acetylcysteine
Jan-Harry Cabungcal et al.
BIOLOGICAL PSYCHIATRY (2013)
SEX DIFFERENCES AND THE ROLE OF ESTROGEN IN ANIMAL MODELS OF SCHIZOPHRENIA: INTERACTION WITH BDNF
Y. C. Wu et al.
NEUROSCIENCE (2013)
Novel G Protein-Coupled Oestrogen Receptor GPR30 Shows Changes in mRNA Expression in the Rat Brain over the Oestrous Cycle
Emma J. Spary et al.
NEUROSIGNALS (2013)
Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species
Bridgette D. Semple et al.
PROGRESS IN NEUROBIOLOGY (2013)
Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: Reversal by clozapine
Bruna Mara Machado Ribeiro et al.
SCHIZOPHRENIA RESEARCH (2013)
Stress in Puberty Unmasks Latent Neuropathological Consequences of Prenatal Immune Activation in Mice
Sandra Giovanoli et al.
SCIENCE (2013)
Effects of an Alpha7 Nicotinic Receptor Agonist and Stress on Spatial Memory in an Animal Model of Alzheimer's Disease
Paloma Vicens et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Behavioral phenotyping of glutathione-deficient mice: Relevance to schizophrenia and bipolar disorder
Anita Kulak et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
N-Acetylcysteine for the Treatment of Glutathione Deficiency and Oxidative Stress in Schizophrenia
Dikoma C. Shungu
BIOLOGICAL PSYCHIATRY (2012)
α7-Nicotinic Receptors and Cognition
Edward D. Levin
CURRENT DRUG TARGETS (2012)
Glutathione Precursor N-Acetyl-Cysteine Modulates EEG Synchronization in Schizophrenia Patients: A Double-Blind, Randomized, Placebo-Controlled Trial
Cristian Carmeli et al.
PLOS ONE (2012)
Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia
David A. Lewis et al.
TRENDS IN NEUROSCIENCES (2012)
Neuroprotective effects of oestrogen against oxidative toxicity through activation of G-protein-coupled receptor 30 receptor
Shui-Bing Liu et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2011)
Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders
Jeremy W. Gawryluk et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action
Olivia Dean et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2011)
The G-protein-coupled estrogen receptor GPER in health and disease
Eric R. Prossnitz et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and D-amphetamine-treated rats: Relevance to schizophrenia and bipolar disorder
Olivia M. Dean et al.
NEUROSCIENCE LETTERS (2011)
The environment and schizophrenia
Jim van Os et al.
NATURE (2010)
Estrogen Promotes Parvalbumin Expression in Arcuate Nucleus POMC Neurons
Peter Sotonyi et al.
REPRODUCTIVE SCIENCES (2010)
Perseverative responding and neuroanatomical alterations in adult heterozygous reeler mice are mitigated by neonatal estrogen administration
Simone Macri et al.
PSYCHONEUROENDOCRINOLOGY (2010)
Involvement of NOX2 in the Development of Behavioral and Pathologic Alterations in Isolated Rats
Stefania Schiavone et al.
BIOLOGICAL PSYCHIATRY (2009)
α7 nicotinic acetylcholine receptor activation ameliorates scopolamine-induced behavioural changes in a modified continuous Y-maze task in mice
John R. Redrobe et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit
K. Radyushkin et al.
GENES BRAIN AND BEHAVIOR (2009)
Gender differences in prepulse inhibition (PPI) in bipolar disorder: men have reduced PPI, women have increased PPI
Andrea Gogos et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
Expression of Estrogen Receptor GPR30 in the Rat Spinal Cord and in Autonomic and Sensory Ganglia
Siok L. Dun et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia
Jared W. Young et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Dose translation from animal to human studies revisited
Shannon Reagan-Shaw et al.
FASEB JOURNAL (2008)
Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation
Fabien Lante et al.
HIPPOCAMPUS (2008)
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
Felicity Ng et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase
M. Margarita Behrens et al.
SCIENCE (2007)
The novel α7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents
Frank G. Boess et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice
Oscar P. Dall'Igna et al.
EXPERIMENTAL NEUROLOGY (2007)
Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat
Z. Abdul-Monim et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Schizophrenia and oxidative stress:: Glutamate cysteine ligase modifier as a susceptibility gene
Mirjana Tosic et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Algorithmically designed peptides ameliorate behavioral defects in animal model of ADHD by an allosteric mechanism
B Kinkead et al.
JOURNAL OF NEUROSCIENCE METHODS (2006)
Altered glutathione redox state in schizophrenia
Jeffrey K. Yao et al.
DISEASE MARKERS (2006)
From dopamine to salience to psychosis - linking biology, pharmacology and phenomenology of psychosis
S Kapur et al.
SCHIZOPHRENIA RESEARCH (2005)
Differential effects of NMDA and AMPA/kainate receptor antagonists on nitric oxide production in rat brain following intrahippocampal injection
L Radenovic et al.
BRAIN RESEARCH BULLETIN (2005)
Discovery and structure -: Activity relationship of quinuclidine benzamides as agonists of α7 nicotinic acetylcholine receptors
AL Bodnar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Gender differences in the prescribing of antipsychotic drugs
MV Seeman
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Sex differences in prepulse inhibition deficits in chronic schizophrenia
V Kumari et al.
SCHIZOPHRENIA RESEARCH (2004)
Effects of dopamine and estrogen upon cortical neurons that express parvalbumin in vitro
NR Ross et al.
DEVELOPMENTAL BRAIN RESEARCH (2002)
Prefrontal cortex, negative symptoms, and schizophrenia: an MRI study
CG Wible et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2001)
Estrogen increases prepulse inhibition of acoustic startle in rats
M Van den Buuse et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia
WM Perlstein et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Regulation of sensorimotor gating in rats by hippocampal NMDA: anatomical localization
NR Swerdlow et al.
BRAIN RESEARCH (2001)